Literature DB >> 3468264

Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides.

Y Li, E Golemis, J W Hartley, N Hopkins.   

Abstract

Moloney murine leukemia virus induces T cell lymphomas after injection into NFS mice, whereas the nondefective Friend virus induces erythroleukemias. Previous studies showed that sequences encompassing the viral transcriptional signals in U3 are the primary determinant of this phenotype in recombinants between these two viruses. To more precisely identify the sequences responsible, we constructed additional recombinants, within U3, between Friend and Moloney viruses and assayed these recombinants for for their disease specificity. We found that a fragment 191 bases long that included the direct repeat (enhancer) region plus 22 nucleotides to its 3' side from Friend virus was sufficient to convert Moloney virus to a virus that induced only erythroleukemias. A 171-base-long fragment of Moloney virus, including just the direct repeat, converted Friend virus to a virus that induced primarily lymphomas (about 85% of mice injected). We also constructed Moloney and Friend virus variants with one rather than two copies of the enhancer element. These viruses retained their disease specificity, although they exhibited a marked increase in the latent period of disease induction. Together the results suggest that 25 or fewer nucleotide differences, lying within and also just 3' of the direct repeat, are the primary determinant of the distinct disease specificities of nondefective Friend and Moloney viruses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3468264      PMCID: PMC254008          DOI: 10.1128/JVI.61.3.693-700.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Regulated expression of a complete human beta-globin gene encoded by a transmissible retrovirus vector.

Authors:  R D Cone; A Weber-Benarous; D Baorto; R C Mulligan
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

2.  RNA-dependent DNA polymerase in virions of RNA tumour viruses.

Authors:  D Baltimore
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

3.  Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40.

Authors:  S A Aaronson; G J Todaro
Journal:  J Cell Physiol       Date:  1968-10       Impact factor: 6.384

4.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

5.  Preparative two-dimensional polyacrylamide gel electrophoresis of 32 P-labeled RNA.

Authors:  R de Wachter; W Fiers
Journal:  Anal Biochem       Date:  1972-09       Impact factor: 3.365

6.  In vitro synthesis of a 9 kbp terminally redundant DNA carrying the infectivity of Moloney murine leukemia virus.

Authors:  E Gilboa; S Goff; A Shields; F Yoshimura; S Mitra; D Baltimore
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

7.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

8.  Retroviruses and embryogenesis: microinjection of Moloney leukemia virus into midgestation mouse embryos.

Authors:  R Jaenisch
Journal:  Cell       Date:  1980-01       Impact factor: 41.582

9.  Transfection of molecularly cloned Friend murine leukemia virus DNA yields a highly leukemogenic helper-independent type C virus.

Authors:  A I Oliff; G L Hager; E H Chang; E M Scolnick; H W Chan; D R Lowy
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

10.  RNase T1-resistant oligonucleotides of B-tropic murine leukemia virus from BALB/c and five of its NB-tropic derivatives.

Authors:  D V Faller; N Hopkins
Journal:  J Virol       Date:  1977-07       Impact factor: 5.103

View more
  91 in total

1.  Sequences between the enhancer and promoter in the long terminal repeat affect murine leukemia virus pathogenicity and replication in the thymus.

Authors:  F K Yoshimura; T Wang; M Cankovic
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  Molecular and phylogenetic analysis of SRS 19-6 murine leukemia virus.

Authors:  L M Bundy; H Fan
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

3.  Differential DNA binding of nuclear proteins to a long terminal repeat region of the MCF13 and Akv murine leukemia viruses.

Authors:  F K Yoshimura; J Tupper; K Diem
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

4.  Contributions to transcriptional activity and to viral leukemogenicity made by sequences within and downstream of the MCF13 murine leukemia virus enhancer.

Authors:  J C Tupper; H Chen; E F Hays; G C Bristol; F K Yoshimura
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

5.  The R-U5-5' leader sequence of neurovirulent wild mouse retrovirus contains an element controlling the incubation period of neurodegenerative disease.

Authors:  J L Portis; S Perryman; F J McAtee
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

6.  A highly efficient retroviral vector allows detection of the transforming activity of the human c-fps/fes proto-oncogene.

Authors:  R A Feldman; D R Lowy; W C Vass; T J Velu
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

7.  A DNA element responsible for the different tissue specificities of Friend and Moloney retroviral enhancers.

Authors:  H J Thiesen; Z Bösze; L Henry; P Charnay
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

8.  Different relative expression from two murine leukemia virus long terminal repeats in unintegrated transfected DNA and in integrated retroviral vector proviruses.

Authors:  K Paludan; H Y Dai; M Duch; P Jørgensen; N O Kjeldgaard; F S Pedersen
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

9.  E- vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy.

Authors:  J G Julias; D Hash; V K Pathak
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Origins of enhancer sequences of recombinant murine leukemia viruses from spontaneous B- and T-cell lymphomas of CWD mice.

Authors:  A C Massey; S C Lawrenz-Smith; D J Innes; C Y Thomas
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.